Timeliness of Prostate Cancer Treatment in Medicare Advantage and Traditional Medicare: More Similarities than Differences?
JCO Oncology Practice · 22.06.2026
DOI: 10.1200/op-26-00534 ↗Kurz gefasst
Editorial in der Zeitschrift JCO Oncology Practice, online erschienen am 22.06.2026. Verfasst von Aaron P Mitchell und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Health Care Policy, Harvard Medical School, Boston, MA.
- Division of General Internal Medicine, Brigham and Women's Hospital, Boston MA.
ORCID-Profile: Aaron P Mitchell, Nancy L Keating
Zitieren
APA
Mitchell, A. P., & Keating, N. L. (2026). Timeliness of Prostate Cancer Treatment in Medicare Advantage and Traditional Medicare: More Similarities than Differences?. JCO Oncology Practice. https://doi.org/10.1200/op-26-00534
Vancouver
Mitchell AP, Keating NL. Timeliness of Prostate Cancer Treatment in Medicare Advantage and Traditional Medicare: More Similarities than Differences?. JCO Oncology Practice. 2026. doi:10.1200/op-26-00534
BibTeX
@article{Mitchell2026,
author = {Mitchell, Aaron P and Keating, Nancy L},
title = {Timeliness of Prostate Cancer Treatment in Medicare Advantage and Traditional Medicare: More Similarities than Differences?},
journal = {JCO Oncology Practice},
year = {2026},
doi = {10.1200/op-26-00534}
}
EUVIMED